Involvement of role of HMGB1-NLRP3 pathway in systemic disorders
Frontiers in Cell and Developmental Biology · 04.07.2025 · 13
DOI: 10.3389/fcell.2025.1600596 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 04.07.2025. Verfasst von Lei Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
High mobility group box-1 (HMGB1) is a protein released from stressed or damaged cells that triggers immune activation and chronic inflammation. The NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) is a central component of the inflammasome, which activates caspase-1 and releases pro-inflammatory cytokines, including IL-1β and IL-18. The HMGB1/NLRP3 axis plays a critical role in regulating inflammation and immune responses, driving systemic inflammation and disease progression. Targeting this pathway offers promising therapeutic strategies for conditions such as autoimmune disorders, trauma, and chronic inflammatory diseases. In particular, inhibiting HMGB1 or NLRP3 can mitigate the exaggerated inflammatory response, reduce tissue damage, and slow disease progression. This review explores the bidirectional interactions between HMGB1 and NLRP3 and discusses current and emerging therapeutic approaches targeting this axis to modulate inflammation and improve clinical outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The First Hospital of Jilin University, Changchun, China.
- Department of Cardiology, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
- Department of Pulmonology, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
- Lithotriptic Center, The First Hospital of Jilin University, Changchun, China.
Zitieren
APA
Yang, L., Li, X., Zhu, X., Ge, F., & Wang, Y. (2025). Involvement of role of HMGB1-NLRP3 pathway in systemic disorders. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1600596
Vancouver
Yang L, Li X, Zhu X, Ge F, Wang Y. Involvement of role of HMGB1-NLRP3 pathway in systemic disorders. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1600596
BibTeX
@article{Yang2025,
author = {Yang, Lei and Li, Xue and Zhu, Xiaoming and Ge, Futao and Wang, Yuantao},
title = {Involvement of role of HMGB1-NLRP3 pathway in systemic disorders},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
volume = {13},
doi = {10.3389/fcell.2025.1600596}
}
EUVIMED